you are watching GranaGard Nano Omega 5
₪ 120.00you are watching GranaGard Nano Omega 5
₪ 120.00
GRANALIX is a biotechnology start-up company, founded by Professor Ruth Gabizon – senior researcher from the Department of Neurology at Hadassah University Hospital, Jerusalem – together with Professor Shlomo Magdassi, an international expert in the field of Nanotechnology from the Casali Center, Institute of Chemistry, at the Hebrew University of Jerusalem.
Research and development of the company's products in nano technology, such as GranaGard nano-omega 5 and NanoGard nano-omega 3, is a product of their joint activity and the extensive knowledge they have acquired over the years in the various research fields. Granlix was founded as a subsidiary of "Yishom" the technology commercialization company of the Hebrew University and "Hadisit" the technology commercialization company of Hadassah.
Professor Ruth Gabizon is a researcher at Hadassah University Hospital in Jerusalem. Prof. Gabizon completed a post-doctorate at the University of California, San Francisco (UCSF) with Professor Stanley Prusiner. Prof. Prusiner is an American Neurologist and Biochemist who discovered a class of pathogens that he named prions; pathological proteins with disease-transmission capacity – for which he received the Nobel Prize in Physiology and Medicine in 1997. In 1988, Prof. Gabizon returned to Israel and continued her research at Hadassah University Hospital.
Professor Shlomo Magdassi is a Professor of Chemistry at the Casali Center for Applied Chemistry at the Hebrew University of Jerusalem. The research group led by Prof. Magdassi focuses on materials science and nanotechnology. Professor Magdassi has published over 220 academic articles and several groundbreaking developments. He is considered a global expert in the field of nanomaterials creation and application.
* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
